Lipoxygenase
Lipoxygenase(脂氧合酶)
Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid. Thre are six LOX isoforms have been found in the humans and mice. 5-Lipoxygenase (5-LOX) is a distinct isoform playing an important role in asthma and inflammation. 5-LOX causes the constriction of bronchioles in response to cysteinyl leukotrienes such as LTC4, thus leading to asthma. 5-LOX also induces neutrophilic inflammation by its recruitment in response to LTB4. 12-Lipoxygenase (12-LOX) is an isoform expressed in epithelial cells and myeloid cells including platelets. 12-LOX can be found in the epithelial cells of the skin. 12-LOX is a potential target for novel anti-platelet therapeutics.15-Lipoxygenase (15-LOX) is expressed in epithelial cells and leukocytes, has different substrate specificity in the humans and mice.15-LOX-1 is a target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
Lipoxygenase 相关产品(254)
- GC424795(S)-HETrECAS: 195061-94-0纯度: >98.00%
A monohydroxy fatty acid synthesized by 5-LO from mead acid
- GC43459Dihydro MontelukastCAS: 142147-67-9纯度: >98.00%
A potential impurity found in commercial montelukast preparations
- GC43616EOS (d18:1/32:1/18:2)CAS: 1318771-31-1纯度: >95.00%
An essential ceramide for prevention of epidermal water loss
- GC44053Leukotriene B4 EthanolamideCAS: 877459-63-7纯度: >97.00%
A theoretical 5-LO metabolite of arachidonoyl ethanolamide
- GC44054Leukotriene C4 methyl esterCAS: 73958-10-8纯度: >97.00%
A more lipid soluble formulation of LTE 4
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC42039 | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC | 154436-51-8 | >98.00% | |
An oxidized phospholipid | ||||
| GC42040 | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE | 947381-58-0 | >98.00% | |
An oxidized phospholipid | ||||
| GC42041 | 1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC | 154436-48-3 | >98.00% | |
An oxidized phospholipid | ||||
| GC42042 | 1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PE | 154436-49-4 | >90.00% | |
An oxidized phospholipid | ||||
| GC42082 | 20-carboxy Leukotriene B4 | 80434-82-8 | >97.00% | |
A LTB 4 metabolite | ||||
| GC42479 | 5(S)-HETrE | 195061-94-0 | >98.00% | |
A monohydroxy fatty acid synthesized by 5-LO from mead acid | ||||
| GC42619 | 8(S)-HETrE | 889573-69-7 | >98.00% | |
A monohydroxy PUFA derivative of DGLA | ||||
| GC42636 | 9(S)-HOTrE | 89886-42-0 | >98.00% | |
A product of the action of 5-LO on α-linolenic acid | ||||
| GC42637 | 9(S)-HpOTrE | 111004-08-1 | >98.00% | |
A 5-LO product derived from α-linolenic acid | ||||
| GC42651 | 9-oxo-10(E),12(E)-Octadecadienoic Acid | 54232-58-5 | >90.00% | |
A natural agonist of PPARα | ||||
| GC42653 | 9-OxoOTrE | 125559-74-2 | >95.00% | |
An antimicrobial oxidized fatty acid | ||||
| GC43153 | CAY10416 | 443919-96-8 | >95.00% | |
A dual COX-2/5-LO inhibitor | ||||
| GC43194 | CAY10698 | 684236-01-9 | >98.00% | |
A selective inhibitor of 12-LO | ||||
| GC43453 | Diflapolin | 724453-98-9 | >99.00% | |
A dual FLAP/sEH inhibitor | ||||
| GC43459 | Dihydro Montelukast | 142147-67-9 | >98.00% | |
A potential impurity found in commercial montelukast preparations | ||||
| GC43616 | EOS (d18:1/32:1/18:2) | 1318771-31-1 | >95.00% | |
An essential ceramide for prevention of epidermal water loss | ||||
| GC44052 | Leukotriene B4 dimethyl amide | 83024-92-4 | >97.00% | |
A LTB 4 receptor antagonist | ||||
| GC44053 | Leukotriene B4 Ethanolamide | 877459-63-7 | >97.00% | |
A theoretical 5-LO metabolite of arachidonoyl ethanolamide | ||||
| GC44054 | Leukotriene C4 methyl ester | 73958-10-8 | >97.00% | |
A more lipid soluble formulation of LTE 4 | ||||
| GC44055 | Leukotriene D4 methyl ester | - | >97.00% | |
A more lipid soluble formulation of LTD 4 | ||||
| GC44056 | Leukotriene E4 methyl ester | - | >97.00% | |
A more lipid soluble formulation of LTE 4 | ||||
| GC44138 | MCTR1 | 1784701-61-6 | ≥95% | |
A specialized pro-resolving mediator | ||||
| GC44139 | MCTR2 | 1784701-62-7 | >97.00% | |
A specialized pro-resolving mediator | ||||
| GC44140 | MCTR3 | 1784701-63-8 | >98.00% | |
A specialized pro-resolving mediator | ||||
